Similar Items: Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management
- Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
- Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients with Diabetes Mellitus Following Heart Transplantation: A Meta-analysis
- Change in Effectiveness and Safety Parameters After Initiation of SGLT2 Inhibitors for Post-Transplant Diabetes Mellitus: A Real-World Observational Study
- Sestrin-2: a new biomarker for type 2 Diabetes Mellitus and Insulin resistance
- Diabetic Retinopathy Severity and Heart Failure Outcomes in Type 2 Diabetes Mellitus
- Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review